The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 Are a Novel Clinical Signature for Predicting Recurrent Osteosarcoma

Bioscience Reports - Netherlands
doi 10.1042/bsr20191251
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portland Press Ltd.

Related search

A Robust Signature Based on Autophagy-Associated LncRNAs for Predicting Prognosis in Lung Adenocarcinoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

A Novel Four‑snoRNA Signature for Predicting the Survival of Patients With Uveal Melanoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Downregulation of AC061961.2, LINGO1-AS1, and RP11-13E1.5 Is Associated With Dilated Cardiomyopathy Progression

Oncotarget
Oncology
2017English

Unscrambling the Genomic Chaos of Osteosarcoma Reveals Extensive Transcript Fusion, Recurrent Rearrangements and Frequent Novel TP53 Aberrations

Oncotarget
Oncology
2015English

Identification of a RNA-Seq Based Prognostic Signature With Five lncRNAs for Lung Squamous Cell Carcinoma

Oncotarget
Oncology
2017English

A Novel Approach for Predicting the Malware Attacks

International Journal of Computer Applications
2019English

Multiple Partial Regularized Nonnegative Matrix Factorization for Predicting Ontological Functions of lncRNAs

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Five Key lncRNAs Considered as Prognostic Targets for Predicting Pancreatic Ductal Adenocarcinoma

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2018English

A Nomogram Based on 9-lncRNAs Signature for Improving Prognostic Prediction of Clear Cell Renal Cell Carcinoma

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy